All News Optimind Pharma Corp.

Equities

OMND

CA68405U1012

Delayed Canadian Securities Exchange Other stock markets 02:36:34 2024-07-16 pm EDT			5-day change	1st Jan Change
0.005 ^CAD	0.00%		0.00%	0.00%

Jul. 03	Optimind Pharma Corp. announced that it expects to receive CAD 0.5 million in funding	CI
Jun. 29	Optimind Pharma Corp. Reports Earnings Results for the Full Year Ended February 29, 2024	CI

All News

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Optimind Pharma Closes First Tranche of Private Placement	Jul. 08	NE
Optimind Pharma - Private Placement	Jul. 03	NE
Optimind Pharma Corp. announced that it expects to receive CAD 0.5 million in funding	Jul. 02	CI
Optimind Pharma Corp. Reports Earnings Results for the Full Year Ended February 29, 2024	Jun. 28	CI
Optimind Pharma Reaches Agreement On Debenture Conversion	Jan. 26	MT
Optimind Pharma Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended November 30, 2023	Jan. 10	CI
Optimind Pharma Corp. Announces Executive Changes	Jan. 08	CI
Optimind Pharma Corp. Reports Earnings Results for the Second Quarter and Six Months Ended August 31, 2023	23-10-30	CI
Optimind Pharma Announces Entry Into Acquisition Agreement With Wolf Acquisitions	23-10-12	GL
Optimind Pharma Corp. Reports Earnings Results for the First Quarter Ended May 31, 2023	23-07-28	CI
Optimind Pharma Corp. Auditor Raises 'Going Concern' Doubt	23-06-27	CI
Optimind Pharma Corp. Reports Earnings Results for the Full Year Ended February 28, 2023	23-06-27	CI
Optimind Acquires MindSetting Institute to Integrate Three-Pronged Approach to its Business and Become Industry Leader in Psychedelic Enhanced Psychotherapy	22-09-21	AQ
Optimind Pharma Corp. acquired MindSetting Inc. from Beatrice Society Inc. for CAD 1.6 million.	22-09-19	CI
Optimind Pharma Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-26	CI
Optimind Pharma Corp. Provides Update on Health Canada's Dealer License Under Joint-Venture with Manitari Pharma Corporation	22-08-10	CI
Reverse Split: 1 of 1.713084	22-08-03	FA
Optimind Pharma Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-08-03	CI
Optimind Pharma Inc. completed the acquisition of Loon Energy Corporation (TSXV:LNE.H) in a reverse merger transaction.	22-07-27	CI
Optimind Pharma Corp. announced that it has received CAD 0.507 million in funding	22-04-03	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Optimind Pharma Corp.

Equities

OMND

CA68405U1012

All News

Filters